NHS watchdog to review evidence on two pioneering Alzheimer’s drugs - Donanemab and lecanemab were licensed for use in the UK in 2024 but were not made available on the NHS after Nice deemed their ben ...

Researchers will join a new NIH-supported network working to develop novel approach methodologies that complement or replace animal testing ...

False diagnoses are used to mask inappropriate use of antipsychotic drugs on patients with dementia, a practice called chemical restraint, a government watchdog report said.

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease.

Experts answer four key questions based on the findings of a study that indicated that low-dose oral lithium could slow ...

A major new study finds people with type 1 diabetes face nearly three times the dementia risk. But lifestyle changes and new treatments offer real hope.

GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...

Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...

“Start low, go slow.” Geriatric pharmacology texts and recent systematic reviews (e.g., on dosing of oncology drugs) warn ...

A new Duke study is exploring whether cells inside the nose could reveal early signs of Alzheimer’s disease. Researchers say ...

HHS Secretary Robert F. Kennedy Jr. appointed Michelle Branham as chair of the federal Advisory Council on Alzheimer’s ...

An assisted living center has been fined $6,000 for a serious medication error that resulted in a resident’s hospitalization.